Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Pilocarpine hydrochloride may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for
Pilocarpine Hydrochloride belongs to a group of medicines called miotics, these medicines affect If you have any doubts about whether you muscles in the eye causing the pupil of the eye should use this medicine talk to your doctor to get smaller. or pharmacist. Pilocarpine Eye Drops are used to treat certain forms of glaucoma (an increase in the pressure within the eye) and to reverse the effect of drugs that cause the pupil of the eye to get bigger.
Pilocarpine Eye Drops with food,drink and alcohol You are advised not to drink alcohol during your treatment with Pilocarpine Eye Drops.
2. What you need to know before Pregnancy, breast-feeding and fertility you use Pilocarpine Eye Drops If you are pregnant or breast feeding, think Do not use Pilocarpine Eye Drops if:
you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Driving and using machines Pilocarpine Eye Drops can cause difficulty in adapting to the dark. You should not drive or use machinery in poor light. The eye drops may also cause blurred vision. If this happens, you should not drive or operate machinery until you can see clearly. Pilocarpine eye drops contains benzalkonium This medicine contains benzalkonium chloride which may cause eye irritation and is known to discolour soft contact lenses. Soft contact lenses must not be worn during treatment with Pilocarpine Eye Drops.
e Pilocarpine Eye Drops 3. How to use Pilocarpine Eye Drops 4. Possible side effects 5. How to store Pilocarpine Eye Drops 6. Contents of the pack and other information
Pilocarpine Eye Drops Always use Pilocarpine Eye Drops exactly as your doctor has told you. Always complete a course of treatment. Do not stop because you feel better. Pilocarpine Eye Drops are for external use only.
Instructions for use 1. Before opening a new bottle of Pilocarpine Eye Drops, please check that the safety strip Eye tests on the front of the bottle is unbroken. Your doctor may want to check your eyes before and during your therapy particularly if you have 2. Tear off the safety strip to break the seal. had any eye disorders. If you have not had your 3. Wash your hands well before use. 4. Remove the outer cap. If you are putting eyes checked recently, tell your doctor. in the eye drops yourself, you should use a mirror. Other medicines and Pilocarpine 5. Tilt your head back and look up at the Please tell your doctor or pharmacist if you ceiling. are taking or have recently taken any other 6. Pull the lower lid of the eye out to form a medicines, including medicines obtained small pocket between your eyelid and your without a prescription. eye. 7. Hold the container between the thumb and Some medicines can interfere with your middle finger of the other hand, turn the treatment. Tell your doctor if you are taking any bottle upside down near to the eye, try not of the following: to touch the eye with the nozzle. 8. Apply enough pressure to the bottle to
11. Repeat steps 5-10 above for your other eye With long term use it is possible that the lens of if you have been told to use Pilocarpine Eye your eye may change shape resulting in changes to your vision. Drops in both eyes. 12. Replace the outer cap on the bottle, trying not to touch the applicator tip with You may not know if you have some of the side anything, including the eye or your fingers. effects. Your doctor will detect them during examinations. 13. Wash your hands. Always use this medicine exactly as described in this leaflet or as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Reporting of side effects Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Your doctor will decide how much you need Healthcare professionals are asked to report based on the severity of your condition and your any suspected adverse reactions via the Yellow response to treatment. Card Scheme Website: http://www.mhra.gov.uk/ yellowcard. Adults (including the elderly) The usual dose is two drops three times daily. Use in children Lowest available dose and concentration should be used at the start of the treatment for children under 18 years of age. Your doctor might increase the dose up to the maximum recommended adult dosage of the 2 % Pilocarpine eye drops depending on the response and tolerability.
Like all medicines, this medicine can cause side effects, although not everyone gets them. Common side effects (may affect 1 and 10 in every 100 patients):
Marketing Authorisation Holder: Martindale Pharmaceuticals Ltd T/a Martindale Pharma Bampton Road Harold Hill Romford Essex RM3 8UG UK Manufacturers: Martindale Pharmaceuticals Ltd Bampton Road Harold Hill Romford Essex RM3 8UG UK Marketing Authorisation numbers: Pilocarpine Eye Drops 1% w/v PL 00156/0079 Pilocarpine Eye Drops 2% w/v PL 00156/0080 Pilocarpine Eye Drops 4% w/v PL 00156/0078 This leaflet was last revised in: 04/2016
D03226
PACKAGE LEAFLET: INFORMATION FOR THE USER
Continued overleaf
100mm Measurement Verification Bar
3226-C
Pilocarpine Eye Drops
Keep this medicine out of the sight and reach of children. Make sure the container is properly closed after each use. Store Pilocarpine Eye Drops in their original container to protect from moisture and away from direct light. Store below 25°C.
If you use more Pilocarpine Eye Drops than Do not use Pilocarpine Eye Drops after the expiry you should date which is printed on the label. The expiry If you are at all concerned that you have used or date refers to the last day of that month. been given too much of this medicine please tell your doctor. Dispose of this medicine 28 days after opening. If you swallow any Pilocarpine Eye Drops Pilocarpine Eye Drops are for external use only. If you have swallowed or you suspect someone else has swallowed any Pilocarpine Eye Drops, contact your doctor or go to the accident and emergency department of your local hospital at once. Always take the container and this leaflet with you if possible, even if empty. If you forget to take Pilocarpine Eye Drops If you miss a dose of Pilocarpine Eye Drops, use them as soon as you remember unless it is nearly time for the next dose, then carry on using it as before. Do not take a double dose to make up for one you have missed.
Medicines should not be disposed of via waste water or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
What Pilocarpine Eye Drops contain The active substance is Pilocarpine hydrochloride 1%, 2% or 4% w/v The other ingredients are benzalkonium chloride and purified water.
If you stop using Pilocarpine Eye Drops You should keep using Pilocarpine Eye Drops for What Pilocarpine Eye Drops look like and as long as your doctor has asked. Your treatment contents of the pack is helping your condition, even if you have not Pilocarpine Eye Drops are a clear, colourless and noticed a difference in how you feel. Should you sterile solution supplied in a plastic dropper need to stop your treatment, your doctor will bottle. Each bottle contains 10ml of the solution. advise you how to do this. If you have any further questions on the use of the medicine, ask your doctor or pharmacist.
Pilocarpine Eye Drops BP 4.0% w/v comes as eye drops. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Pilocarpine Eye Drops BP 4.0% w/v is pilocarpine hydrochloride.
Medicines with the same active substance, strength and form include: Pilocarpine Eye Drops BP 1.0% w/v, Pilocarpine Eye Drops BP 1.0% w/v (Tubilux), Pilocarpine Eye Drops BP 2.0% w/v. In total there are 5 equivalent products. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Pilocarpine Eye Drops BP 4.0% w/v, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
• Pilocarpine is a direct acting miotic indicated for:• chronic simple glaucoma• acute (closed angle) glaucoma alone, or in conjunction with other agents to decrease intra-ocular pressure prior to surgical treatment• miosis - to counteract the effects of cycloplegic or mydriatic eye drops
Posology Adults and the elderly
a) In the treatment of open angle glaucoma, the dosage is one or two drops every six hours or as prescribed by the physician.The strength of the preparation and the frequency of use are determined by the severity of the condition and the response to treatment.b) When used prior to surgery for acute attacks of closed-angle glaucoma, the dosage is one drop every five minutes until miosis is obtained or as directed by the physician.c) To overcome weaker mydriatics, the normal dosage is one drop every five minutes until the effect is counteracted or as directed by the physician. Paediatric population
Based on the infrequency of reports of adverse events in children, and the extensive experience of use of pilocarpine in childhood glaucoma, concentrations of up to 2% may be safely used in children. Currently available data are described in section 5.1 but no recommendation on a posology can be made.Treatment should be started with the lowest available dose and concentration in patients under 18 years of age. Depending on clinical response and tolerability, the dose may be increased up to the maximum recommended adult dosage of the 2% pilocarpine eye drop solution. Directly after administration of any dose, the lacrimal punctum should be occluded for one minute with a finger to limit systemic exposure. Method of administration
Eye drops for topical administration into the conjunctival sac.
• Hypersensitivity to any component.• Acute iritis• Anterior uveitis• Some forms of secondary glaucoma• Soft contact lenses.Hypersensitivity to the active substances(s) or to any of the excipients listed in section 6.1.
Although rare, the possibility of systemic absorption should be considered especially in the treatment of acute closed-angle glaucoma where higher doses are administered. It should be used with caution in patients with bronchial asthma, peptic ulceration, urinary tract obstruction, Parkinson's disease, acute heart failure and hypertension.Fundus examination is advised in all patients before starting pilocarpine therapy since retinal detachment has been associated with the use of miotics in susceptible individuals and those with pre-existing retinal disease. Regular monitoring of visual fields and intra-ocular pressure should be carried out in patients on long term therapy with pilocarpine for chronic simple glaucoma.
If systemic absorption occurs, pilocarpine may enhance the effects of alcohol and anticholinesterases and diminish the effects of anticholinergics. The effects of pilocarpine may be enhanced by anticholinesterases, MAOI's, phenothiazines, antihistamines and tricyclic antidepressants. Adrenergic blockers may decrease the effects of pilocarpine. Paediatric population
Interaction studies have only been performed in adults.
Pregnancy
Safety of pilocarpine for use during pregnancy has not been established. Ophthalmic pilocarpine may be systemically absorbed and mothers using the drug may give birth to infants with signs mimicking neonatal meningitis such as restlessness, convulsions, diaphoresis and hypothermia. Pilocarpine should therefore only be used during pregnancy when essential. Breast-feeding
Safety of pilocarpine for use during lactation has not been established and it should therefore only be used when clearly indicated. It is not known whether pilocarpine is excreted in breast milk. The possibility of systemic absorption however, should be borne in mind.
The miotic effects of pilocarpine cause difficulty in adapting to the dark. Caution is therefore necessary if driving or operating machinery in poorly lit conditions. Pilocarpine impairs accommodation by paralysis or spasm and patients should not drive or operate machinery if they experience blurred vision.
Adverse drug reactions from clinical trials are listed by MedDRA system organ class. Within each system organ class, the adverse drug reactions are ranked by frequency, with the most frequent reactions first. In addition, the corresponding frequency category for each adverse drug reaction is based on the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data). System Organ Class Frequency Undesirable effect
Eye disorders Common decreased visual acuity in poor illumination (frequently experienced by older individuals and in those patients with lens opacity), itching, smarting (discomfort) and burning, sensitisation of the lids and conjunctival vascular congestion, superficial keratitis, ciliary spasm, blurred vision, induced myopia, transient myopia, lens changes with chronic use, increased pupillary block, vitreous haemorrhages, retinal detachments.
rare lacrimation
Nervous system disorder Common Headache and browache(especially in younger patients who have recently initiated therapy),
rare sweating, increased salivation, tremor
Cardiac disorders rare changes in cardiac rhythm
Vascular disorders rare changes in blood pressure
Respiratory, thoracic and mediastinal disorders rare bronchial spasm, pulmonary oedema
Gastrointestinal disorders rare nausea, vomiting and diarrhoea
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme Website: http://www.mhra.gov.uk/yellowcard.
If pilocarpine is accidentally ingested, emesis should be induced or gastric lavage performed. The patient should be monitored for signs of pilocarpine toxicity such as increased salivation and sweating, lacrimation, nausea, vomiting and diarrhoea. If these occur, therapy with an anticholinergic such as atropine may be required.
Ask anything about Pilocarpine Eye Drops BP 4.0% w/v. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.